NLRP3 and metabolic dysfunction-associated steatotic liver disease: An expanding body of evidence highlights the central role of NLRP3 inflammasomes in the development of numerous liver conditions, encompassing alcoholic and nonalcoholic fatty liver diseases, as well as liver injury [12, 28–31].